Cormorant Asset Management, LP - RA PHARMACEUTICALS INC ownership

RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 125 filers reported holding RA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of RA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$13,873,000
+98.4%
295,6000.0%0.55%
+30.0%
Q3 2019$6,991,000
-33.6%
295,600
-15.5%
0.43%
-29.6%
Q2 2019$10,525,000
+17.5%
350,000
-12.5%
0.60%
-0.2%
Q1 2019$8,960,000
+11.6%
400,000
-9.3%
0.61%
-7.1%
Q4 2018$8,026,000441,0000.65%
Other shareholders
RA PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
NEA Management Company, LLC 6,138,797$288,094,00013.62%
RA Capital Management 4,858,260$227,998,0006.91%
HAVENS ADVISORS LLC 116,000$5,444,0004.77%
ALPINE ASSOCIATES MANAGEMENT INC. 2,115,600$99,286,0003.16%
SYQUANT CAPITAL SAS 129,690$6,086,0003.13%
BARDIN HILL MANAGEMENT PARTNERS LP 391,758$18,386,0003.02%
Kellner Capital, LLC 91,100$4,275,0002.71%
Telemetry Investments, L.L.C. 17,100$803,0002.68%
Versor Investments LP 1,002,649$47,054,0002.38%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,519,718$71,320,0002.28%
View complete list of RA PHARMACEUTICALS INC shareholders